AdiMap
AdiMap48About
What does AdiMap do?
Adimab is a premier antibody discovery and engineering platform that delivers therapeutic proteins, including IgGs, HCAbs, multispecifics, and TCRs, from concept to clinic. Their proprietary yeast-based platform enables the efficient discovery and engineering of highly specific, stable, and developable antibody candidates. Adimab partners with biopharma companies to advance therapeutic programs and improve patient outcomes.
What is AdiMap's revenue?
StartupHub estimates AdiMap's annual revenue at $37.2M (range $27.8M to $44.4M, 62% confidence), based on comparable companies in the sector.
What is AdiMap's valuation?
StartupHub estimates AdiMap's effective valuation at $2.0B (range $1.4B to $2.5B, 27% confidence), based on comparable companies in the sector.
How much funding has AdiMap raised?
AdiMap has raised a total of $438M in funding. The most recent round on record is Series D.
Where is AdiMap headquartered?
AdiMap is headquartered in Lebanon, United States.
When was AdiMap founded?
AdiMap was founded in 2010.
What industry does AdiMap operate in?
AdiMap operates in Fintech, Trading, Intelligence, Data Science, Financial Graph, Algorithms.
How many employees does AdiMap have?
AdiMap has approximately 139 people on record.
No comments yet. Be the first to share your take.